The government today announced a £133 million investment in new research to improve diagnosis, treatment and care options for diseases like cancer, dementia, arthritis and Parkinson’s.
The funding will unlock new treatments, including new gene-based therapies and artificial intelligence, which is expected to help thousands of NHS patients.
NHS diagnostic services will receive £50 million to support the work of existing Centres of Excellence – based in Leeds, Oxford, Coventry and London – in digital pathology and imaging with artificial intelligence.
Adult social care will also receive £14 million for bioscience projects and technologies across the UK that could treat diseases such as osteoarthritis and develop new vaccines, and another £7.5 million for research on care delivery improvement.
“Curing these kinds of debilitating illnesses is one of the great challenges we face globally, and today’s commitment will play a vital role in ensuring that our scientists and thinkers have the tools they need to find new treatments that will support people to lead longer, healthier lives,” said Business Secretary Andrea Leadsom.
A further £69.5 million of the total investment through UK Research and Innovation will help fund 4 British projects.
Health Secretary Matt Hancock said, “none of this would be possible without the long-term plan, backed by an extra £33.9 billion a year for the NHS”.
“The NHS is now spearheading world-leading technologies that can transform and save lives through new treatments, diagnosis techniques and care. I’m determined that the benefits of these advances will improve the lives of thousands of patients whose conditions have long been considered life-limiting,” he added.